Conference Reports for NATAP

Back

12th International HIV Drug Resistance Workshop   June 10-14, 2003, Los Cabos, Mexico     3TC Residual Antiviral Activity Despite M184V Resistance - (6/25/03)   TMC-114, new protease inhibitor for PI resistance - (6/23/03)   Short-Duration, Single-Drug Interruption Strategy - (6/19/03)   Tenofovir Resistance at the HIV Drug Resistance Workshop - (6/17/03)   Transmission of Drug Resistance in Newly Infected - (6/16/03)   Genotype Testing Did Not Detect Low Level NNRTI Mutations and Tenofovir Resistance, Single-Drug Treatment Interruption, 3TC Efficacy Persists Despite Resistance - (6/16/03)   TMC-125: a new NNRTI, early study results - (6/12/03)   Elvucitabine (ACH-126,433, L-Fd4C) - (6/12/03)   Super-Infection and Co-Infection - (6/12/03)   12th International HIV Drug Resistance Workshop - (6/11/03)